News Investment in Eagle Genomics Ltd.

OMRON VENTURES CO., LTD. (HQ: Minato-ku, Tokyo; CEO: Tomoko Inoue; hereinafter, “OVC”) is pleased to announce that it has made an investment in Eagle Genomics Ltd. (HQ: Cambridge, United Kingdom; CEO: Anthony Finbow; hereinafter, “Eagle Genomics”), which has developed an AI-augmented knowledge discovery platform, the e[datascientist]TM.

The microbiome is an ecosystem of microorganisms existing symbiotically in the bodies of humans, animals, and other organisms. Knowledge of the microbiome, and host-microbiome interactions in humans, animals and the environment is critical to solving for ‘One Health’ challenges in the Food and Nutrition, Beauty, and Personal Care, AgBio and BioPharma industries. However, the analysis of complex, multi-dimensional data, including microbiome and host-microbiome interactions, has previously been extremely challenging.

To overcome these challenges, Eagle Genomics has developed the e[datascientist]TM, powered by network science and multilayer hypergraph technology. It applies machine learning and AI to create and drive data-driven insight journeys that solve complex problems at scale. By networking multi-dimensional microbiome and other data, the e[datascientist] extracts invaluable data insights in minutes rather than months. It helps companies carry out science-led innovation for next-generation products by delivering robust, scientifically underpinned product claims.

Past or without Eagle Genomics:Tedious processes, scientists have to manage every steps themselves absorbing precious focus time that is better spent on research / e[datascientist]:Starting from a hypothesis, scientists can query a semantic data fabric to accelerate R&D and innovation by generating results and novel insights

Through its investment in Eagle Genomics, OVC is committed to accelerating developments related to the microbiome, and contributing to research and development in the extension of healthy lifespans and the treatment of disease.

Eagle Genomics Ltd. Company Profile

Company Name Eagle Genomics Ltd.
CEO Anthony Finbow
Location Head Office: Cambridge, United Kingdom
Founding date 2008
Business description Developer of a knowledge discovery platform for the microbiome


OMRON VENTURES CO., LTD. is a corporate venture capital established to create innovation driven by social needs by investing and engaging in joint development with startups from around the globe with original technologies and ideas, with a view toward offering solutions to social issues laid out in OMRON’s Medium- to Long-Term Vision SF2030. Currently, focus domains for its investments include FA, smart cities,digital health,and energy management.
For details, please visit

About OMRON Corporation

OMRON Corporation is a global leader in the field of automation based on its core technology of “Sensing & Control + Think.” OMRON’s business fields cover a broad spectrum, ranging from industrial automation and electronic components to social systems, healthcare. Established in 1933, OMRON has about 30,000 employees worldwide, working to provide products and services in around 120 countries and regions.
For more information, please visit

Contact from Media:

Arihiro Yokota, Corporate Communications Group,
Brand Communications Department, OMRON Corporation
TEL: +81-75-344-7175